Learning Objective: By completing this Nano Learning course, participants will be able to:
- Describe why large pharmaceutical companies acquire clinical-stage biotech firms and how patent cliffs drive M&A strategy.
- Explain the purchase price allocation process for a biotech acquisition, including valuation and subsequent accounting for in-process R&D and platform technology.
Category: Accounting
Level: Basic
Credits: 0.2
Prerequisites: None
Advance Prep: None
Delivery Method: Nano Learning
Course Assessment
🎉 Congratulations!
You have successfully passed this course.
Your certificate has been generated and is ready for download.
